CLMT Calumet, Inc. /DE
Petroleum Refining · Nasdaq · SEC CIK 2013745 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY28.4%
TTM net income YoY-421.0%
TTM EPS YoY-428.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin9.1%
Operating margin3.4%
Net margin-3.7%
FCF margin5.1%
EBITDA margin6.5%
Returns
ROE—
ROA-6.8%
ROIC (approx.)11.2%
Asset turnover1.81x
Leverage & solvency
Liabilities / assets120.1%
Debt / equity—
Current ratio1.06x
Interest coverage0.87x
Cash quality & payout
Operating cash flow / net income-1.76x
Accruals ratio-18.7%
Payout ratio—
Capex / revenue1.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $4.14B | $4.19B |
| Cost of revenue | $3.89B | $3.96B |
| Gross profit | $245.70M | $230.80M |
| SG&A expense | $123.80M | $145.50M |
| Operating income | $108.70M | $8.10M |
| Interest expense | $215.80M | $236.70M |
| Pretax income | -$126.40M | -$221.20M |
| Income tax | -$92.60M | $800,000 |
| Net income | -$33.80M | -$222.00M |
| EBITDA | $257.50M | $157.10M |
| EPS (basic) | -0.39 | -2.67 |
| EPS (diluted) | -0.39 | -2.67 |
| Weighted avg. shares (diluted) | 86.76M | 83.15M |
| Balance sheet | ||
| Cash & equivalents | $125.10M | $45.90M |
| Receivables | $232.50M | $278.10M |
| Inventory | $385.20M | $416.30M |
| Current assets | $857.80M | $766.00M |
| PP&E, net | $1.35B | $1.44B |
| Goodwill | $140.50M | $173.00M |
| Intangibles | $8.70M | $22.00M |
| Total assets | $2.69B | $2.76B |
| Current liabilities | $840.70M | $863.60M |
| Short-term debt | $156.20M | $35.50M |
| Long-term debt | $2.08B | $2.06B |
| Total debt | $2.23B | $2.10B |
| Total liabilities | $3.18B | $3.22B |
| Shareholders' equity | -$732.70M | -$711.90M |
| Net debt | $2.11B | $2.05B |
| Shares outstanding | 86.78M | 85.95M |
| Cash flow statement | ||
| Operating cash flow | $108.90M | -$46.40M |
| Capital expenditure | $52.30M | $76.70M |
| Free cash flow | $56.60M | -$123.10M |
| Investing cash flow | $44.10M | -$76.70M |
| Financing cash flow | $6.20M | $154.30M |
| Depreciation & amortization | $148.80M | $149.00M |
| Stock-based compensation | -$4.50M | $14.60M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.